Form 4 for HALO HALOZYME THERAPEUTICS, INC.
Accepted 2025-02-18 00:00:00 ET · period of report 2025-02-15 · accession 0001415889-25-004507 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-18 | 2025-02-15+ | HALO | LaBrosse Nicole | SVP, CFO | M - OptEx | $0.00 | +29.1K | 31.7K | +1,120% | $0 |
| DM | 2025-02-18 | 2025-02-15+ | HALO | LaBrosse Nicole | SVP, CFO | F - Tax | $58.29 | -15.8K | 26.4K | -37% | -$918.2K |
| DM | 2025-02-18 | 2025-02-15+ | HALO | LaBrosse Nicole | SVP, CFO | M - OptEx | $0.00 | -29.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-15 | M | A | 1,254 | $0.00 | 16,734 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-15 | F | D | 741 | $58.29 | 15,993 | D | — | — | (F1) The reported disposition of 741 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| 3 | Common | Common Stock | 2025-02-16 | M | A | 17,409 | $0.00 | 33,402 | D | — | — | |
| 4 | Common | Common Stock | 2025-02-16 | F | D | 9,400 | $58.29 | 24,002 | D | — | — | (F2) The reported disposition of 9,400 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| 5 | Common | Common Stock | 2025-02-16 | M | A | 5,093 | $0.00 | 29,095 | D | — | — | |
| 6 | Common | Common Stock | 2025-02-16 | F | D | 2,869 | $58.29 | 28,813 | D | — | — | (F4) The reported disposition of 2,869 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| 7 | Common | Common Stock | 2025-02-16 | F | D | 2,742 | $58.29 | 26,353 | D | — | — | (F3) The reported disposition of 2,742 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| 8 | Common | Common Stock | 2025-02-16 | M | A | 5,329 | $0.00 | 31,682 | D | — | — | |
| 9 | Derivative | Restricted Stock Units | 2025-02-16 | M | D | 5,093 | $0.00 | 5,093 | D | $0.00 · — to — | 5,093 Common Stock | (F5) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. |
| 10 | Derivative | Restricted Stock Units | 2025-02-16 | M | D | 5,329 | $0.00 | 10,658 | D | $0.00 · — to — | 5,329 Common Stock | (F5) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. |
| 11 | Derivative | Restricted Stock Units | 2025-02-15 | M | D | 1,254 | $0.00 | 0 | D | $0.00 · — to — | 1,254 Common Stock | (F5) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. |
| 12 | Derivative | Performance Stock Units | 2025-02-16 | M | D | 17,409 | $0.00 | 0 | D | $0.00 · — to — | 17,409 Common Stock | (F6) This transaction represents the vesting and settlement of performance stock units in shares of common stock of the issuer. |